World health organization studies of prostaglandins versus saline as abortifacients: A reappraisal

Obstetrics and Gynecology

Volumn 52, Issue 4, 1978, Pages 493-498

  Cates, Willard ^a   Grimes, David A ^a   Schulz, Kenneth F ^a   Ory, Howard W ^a   Tyler, Carl W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN; PROSTAGLANDIN F2 ALPHA; SODIUM CHLORIDE;

ABORTION; AMNION FLUID; DRUG ADMINISTRATION; INDUCED ABORTION; MAJOR CLINICAL STUDY; PREGNANCY; THERAPEUTIC ABORTION; WORLD HEALTH ORGANIZATION;

ABORTIFACIENT AGENTS--LEGAL ASPECTS; ABORTION, DRUG INDUCED; ABORTION, INDUCED; BIOLOGY; COMPARATIVE STUDIES; CURETTAGE; ENDOCRINE SYSTEM; EVALUATION; FAMILY PLANNING; FERTILITY CONTROL, POSTCONCEPTION; INGREDIENTS AND CHEMICALS; INTERNATIONAL AGENCIES; OBSTETRICAL SURGERY; ORGANIZATIONS; PHYSIOLOGY; PREGNANCY; PREGNANCY, FIRST TRIMESTER; PREGNANCY, SECOND TRIMESTER; PROSTAGLANDINS; REPRODUCTION; RESEARCH METHODOLOGY; SALINE SOLUTION, HYPERTONIC; STUDIES; SURGERY; TREATMENT; UN; WHO;

ABORTION, INDUCED; AMNION; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DILATATION AND CURETTAGE; FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PROSTAGLANDINS F; SALINE SOLUTION, HYPERTONIC; SODIUM CHLORIDE; TIME FACTORS; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 0017863448     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Karim SSM, Filshie GM: Therapeutic abortion using prostaglandin F2α. Lancet 1:157-159, 1970
2. Embrey MP, Hillier K: Therapeutic abortion by intrauterine instillation of prostaglandins. Br Med J 1:588-590, 1971
3. Bygdeman M, Toppozada M, Wiqvist N: Induction of midtrimester abortion by intra-amniotic administration of prostaglandin F2α. Acta Physiol Scand 82:415-418, 1971
4. Brenner WE: The current status of prostaglandins as abor-tifacients. Am J Obstet Gynecol 123:306-328, 1975
5. World Health Organization (WHO) Task Force on the Use of Prostaglandins for the Regulation of Fertility: comparison of intraamniotic prostaglandin F2αand hypertonic saline for induction of second-trimester abortion. Br Med J 1:1373-1376, 1976
6. WHO Task Force on the Use of Prostaglandins for the Regulation of Fertility: Prostaglandins and abortion. III. Comparison of single intra-amniotic injections of 15-methyl prostaglandin F2αand prostaglandin F2αfor termination of second-trimester pregnancy: An international multicenter study. Am J Obstet Gynecol 129:601-605, 1977
7. WHO Task Force on the Use of Prostaglandin for the Regulation of Fertility: Prostaglandins and abortion. II. Single extra-am-niotic administration of 0.92 mg. of 15-methyl prostaglandin F2αin Hyskon for termination of pregnancies in weeks 10 to 20 of gestation: An international multicenter study. Am J Obstet Gynecol 129:597-600, 1977
8. WHO Task Force on the Use of Prostaglandins for the Regulation of Fertility: Prostaglandins and abortion. I. Intramuscular administration of 15-methyl prostaglandin F2αfor induction of abortion in weeks 10 to 20 of pregnancy. Am J Obstet Gynecol 129:593-596, 1977
9. WHO Task Force on the Use of Prostaglandins for the Regulation of Fertility: Repeated vaginal administration of 15-methyl PGF2α methyl ester for termination of pregnancy in the I3th-20th week of gestation. Contraception 16:175-181, 1977
10. Bygdeman M: Comparison of efficacy and complications following administration of prostaglandin or hypertonic saline for termination of second trimester pregnancy. Obstet Gynecol 52:424-429, 1978
11. Grimes DA, Schulz KF, Cates W Jr, et al: Midtrimester abortion by intra-amniotic prostaglandin F2α. Safer than saline? Obstet Gynecol 49:612-616, 1977
12. Ederer F: The randomized controlled clinical trial. Am J Ophthalmol 79:1-38, 1975
13. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 34:585-612, 1976
14. Royall RM: Current advances in sampling theory: Implications for human observational studies. Am J Epidemiol 104:463-474, 1976
15. Taylor ES: Summary of "Comparison of intra-amniotic prostaglandin F2αand hypertonic saline for induction of second trimester abortion." Obstet Gynecol Surv 32:148-149, 1977
16. Kawada CY: Techniques of second-trimester abortions. Clin Ob-stet Gynecol 20:833-847, 1977
17. Tielze C: Induced abortion: Reports on Pop/Fam Plann 14. Second edition. Suppl 13, 1977
18. Cates W Jr, Grimes DA, Haber RJ, et al: Abortion deaths associ ated with the use of prostaglandin F2α. Am J Obstet Gynecol 127:219-222, 1977
19. Cates, W Jr, Grimes DA, Smith JC, et al: The risk of dying from legal abortion in the United States, 1972-1975. Int J Gynaecol Obstet 15:172-176, 1977
20. Burt RL, Connor ED, Davidson IWF: Hypokalemia and cardiac arrhythmia associated with prostaglandin-induced abortion. Obstet Gynecol 50(Suppl):45s-46s, 1977
21. Cates W Jr. Jordaan HVF: Sudden collapse and death after abortions induced by prostaglandin F2α. Am J Obstet Gynecol (In press)
22. Lippes J, Stale University of New York, Buffalo, New York. Patterson S, Baptist Memorial Hospital, Memphis, Tennessee (Unpublished data)
23. Stroh G, Hinman AR: Reported live births following induced abortion: Two and one-half years' experience in upstate New York. Am J Obstet Gynecol 126:83-90, 1976
24. Lee WK, Baggish MS: Live births as a complication of second-trimester abortion induced with intra-amniotic prostaglandin F2α. Adv Plann Parenthood (In press)
25. Grimes DA, Schulz K F, Cates W Jr, et al: Mid-trimester abortion by dilatation and evacuation. A safe and practical alternative. N Engl J Med 296:1141-1145, 1977
26. Frienian SM, Wulff GJL: Management of uterine perforation following elective abortion. Obstet Gynecol 50:647-650, 1977
27. Calcs W Jr, Schulz KF, Grimes DA, et al: Effect of delay and choice of method on risk of abortion morbidity. Fam Plann Perspect 9:266-273, 1977
28. Grimes DA, Cates W Jr: Gestational age limit of twelve weeks for abortion by curettage. Am J Obstet Gynecol (In press)
29. Tielze C, Lewit S: Joint Program for the Study of Abortion (JPSA): Early medical complications of legal abortion. Stud Fam Plann 3(6):97-124, 1972
30. Stewart GK. Goldstein P: Medical and surgical complications of therapeutic abortions. Obstet Gynecol 40:539-542, 1972
31. Brenner WE, Edelman DA: Dilatation and evacuation at 13 to 15 weeks' gestation versus intra-amniotic saline after 15 weeks gestation. Contraception 10:171-180, 1974
32. Hodari AA, Peralta J, Quiroga PJ, et al: Dilatation and curettage for second-trimester abortions. Am J Obstet Gynecol 127:850-854, 1977
33. Hern WM, Oakes AG: Multiple laminaria treatment in early mid-trimesler outpatient suction abortion: A preliminary report. Adv Plann Parenthood 12:93-97, 1977
34. Smith RG, Steinhoff PG, Palmore JA: Potential reduction of medical complications from induced abortions. Int J Gynaecol Obstet 15:337-346, 1978
35. Burnhill MS: Vaginal second-trimester abortion, Risks, Benefits, and Controversies in Fertility Control Edited by JJ Sciarra, et al. Hagerstown, Md, Harper & Row, 1978, pp 331-347
36. Peterson WF: Dilatation and evacuation: Patient evaluation and surgical techniques, Pregnancy Termination: Procedures, Safety and New Developments. Edited by GI Zatuchni. (In press)
37. Stubblefield PG, Albrecht BH, Koos B, et al: A randomized study of 12-mm and 15.9-mm cannulas in midtrimester abortion by laminaria and vacuum curettage. Fertil Steril 29:512-517, 1978
38. Lauersen NH, Wilson KH, Zervoudakis IA, et al: Management of failed prostaglandin abortions. Obstet Gynecol 47:473-478, 1976
39. Burkman RT, Atienza MF, King TM, et al: The management of midlrimester abortion failures by vaginal evacuation. Obstet Gynecol 49:233-236, 1977
40. Goldsmith S, Kaltrieder NB, Margolis AJ: Second-trimester abortion by dilatation and extraction (D&E): Surgical techniques and psychological reactions. (Unpublished data)
41. Bierer I, Steiner V: Termination of pregnancy in second trimester with the aid of laminaria tents. Med Gynaec Soc 6:9-10, 1971
42. Slome J: Termination of pregnancy. Lancet 2:881-882, 1972
43. Davis G: Mid-trimester abortion. Lancet 2:1026, 1972
44. Finks AA: Mid-trimester abortion. Lancet 1:263-264, 1973
45. Van den Bergli AS: Abortion procured in the second trimester of pregnancy. Medisch Contact 29:155-1560, 1974
46. Van Lith DAF, Beekhuizen W, Van Schie KJ: Complications of aspirolomy, a modified dilatation and curettage procedure for terminating early second trimester pregnancies. Pregnancy Termination: Procedures, Safety and New Developments. Edited by GI Zatuchni. (In press)
47. Von Allmen SD, Cates W Jr, Schulz KF, et al: Cost of treating abortion-related complications. Fam Plann Perspect 9:273-276, 1977
48. Rooks JP, Cates W Jr: Emotional impact of D&E versus instillation. Fam Plann Perspect 9:276-277, 1977